Johnson & Johnson CEDEAR (JNJC)
BCBA
17.43
+0.40 (+2.35%)
Closed
Oct 9, 2026
Day's Range
17.4317.43
52 wk Range
12.2018.59
Overview - JNJC - Johnson & Johnson CEDEAR
Key Statistics
Trading
Average Volume
39
Peers - JNJC - Johnson & Johnson CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- JNJCBCBAJohnson & Johnson CEDEAR+33.37%52-week change—P/E (Trailing)—Profit Margin
- GILDBCBAGilead Sciences Inc.+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.+35.08%52-week change4.90P/E (Trailing)‪18.87%‬Profit Margin
- MRKBCBAMerck & Co., Inc. CEDEAR+51.25%52-week change2.52P/E (Trailing)‪4.76%‬Profit Margin
- LLYBCBAEli Lilly and Company CEDEAR+43.62%52-week change0.19P/E (Trailing)‪33.52%‬Profit Margin
- BIIBBCBABiogen Inc. CEDEAR+43.89%52-week change3.32P/E (Trailing)‪8.32%‬Profit Margin
- AMGNBCBAAmgen Inc. Cedear+39.00%52-week change0.18P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - JNJC - Johnson & Johnson CEDEAR
About
Johnson & Johnson CEDEAR is an Argentine depositary receipt that represents an economic interest in Johnson & Johnson’s ordinary shares, allowing local investors to access the company’s global healthcare exposure in pesos through Argentina’s capital market. Each receipt represents a fractional interest designed to…
SectorHealthcare
IndustryDrug Manufacturers - General
Employees138.20K
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
